Arbutus Biopharma upgraded to neutral from underperform at Wedbush, price target $5

1 News Net

1 News - 1 Movies - 1 Music - 1 eBooks - 1 Search

 

Arbutus Biopharma upgraded to neutral from underperform at Wedbush, price target $5

Arbutus Biopharma upgraded to neutral from underperform at Wedbush, price target $5

1 News Net

1 News - 1 Movies - 1 Music - 1 eBooks - 1 Search

 

Leave a Reply